Un Jung Kang, MD
H. Houston Merritt Professor of Neurology
Chief, Movement Disorders Division
Neurology, American Board of Psychiatry and Neurology
Insurance: Aetna, CIGNA, Empire BC/BS, HIP, Oxford, UHC, Medicare
*Please verify insurance participation with the physician's office when making an appointment.
» Division of Parkinson's Disease and Other Movement Disorders
» Department of Neurology
» Recent Publications
Dr. Kang is a specialist in movement disorders with over 30 years of expertise in patient care, the education of specialty physicians, and research on understanding and treating these disorders.
In research, Dr. Kang is focused on 1) understanding the mechanisms of dopaminergic therapy in order to maximize its efficacy and 2) understanding the mechanisms of neurodegeneration in Parkinson's disease (PD) to gain insights for potential neuroprotective therapies. His lab has been studying the non-dopaminergic mechanisms underlying both the beneficial aspects of the dopaminergic therapy, such as motor learning, that produces long-duration response and detrimental ones, such as dyskinesia. He is also interested in pathogenic mechanisms of PD and investigates interaction of PD causing genes such as DJ-1 and PINK1 with environmental exposures in producing neurodegeneration.
Parkinson's disease, Parkinsonism, Multiple system atrophy, Progressive supranuclear palsy, dystonia, Huntington's disease, tics, tremor and other neurodegenerative disorders.
Botulinum toxin injection for movement disorders such as spasmodic torticollis, blepharospasm, hemifacial spasm, and writer's cramp.
Awards and Honors:
The Teacher of the Year Award, Department of Neurology, University of Chicago
National Parkinson Foundation, Richard E. Heikkila Research Scholar Award
Parkinson's Disease Foundation & United Parkinson Foundation Joint Junior Faculty Award